SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-22-106928
Filing Date
2022-04-15
Accepted
2022-04-15 17:27:21
Documents
8

Document Format Files

Seq Description Document Type Size
1 F-3 d272618df3.htm F-3 787265
2 EX-1.2 d272618dex12.htm EX-1.2 262264
3 EX-5.1 d272618dex51.htm EX-5.1 32914
4 EX-23.2 d272618dex232.htm EX-23.2 1626
5 EX-FILING FEES d272618dexfilingfees.htm EX-FILING FEES 31803
6 GRAPHIC g272618g00g10.jpg GRAPHIC 77499
7 GRAPHIC g272618g0415012443060.jpg GRAPHIC 2779
8 GRAPHIC g272618g04y63.jpg GRAPHIC 28252
  Complete submission text file 0001193125-22-106928.txt   1266965
Mailing Address SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL EAST R&D BUILDING, 3RD FLOOR 6 BEIJING WEST ROAD, TAICANG F4 215400
Business Address SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL EAST R&D BUILDING, 3RD FLOOR 6 BEIJING WEST ROAD, TAICANG F4 215400 86 512 5357 7866
Connect Biopharma Holdings Ltd (Filer) CIK: 0001835268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-264340 | Film No.: 22830699
SIC: 2834 Pharmaceutical Preparations